Search by Drug Name or NDC
NDC 16729-0332-05 oxaliplatin 5 mg/mL Details
oxaliplatin 5 mg/mL
oxaliplatin is a INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Accord Healthcare Inc.. The primary component is OXALIPLATIN.
MedlinePlus Drug Summary
Oxaliplatin is used with other medications to treat advanced colon or rectal cancer (cancer that begins in the large intestine). Oxaliplatin is also used with other medications to prevent colon cancer from spreading in people who have had surgery to remove the tumor. Oxaliplatin is in a class of medications called platinum-containing antineoplastic agents. It works by killing cancer cells.
Related Packages: 16729-0332-05Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Oxaliplatin Injection
Product Information
| NDC | 16729-0332 |
|---|---|
| Product ID | 16729-332_0e2ec613-5375-858e-e063-6294a90ab95a |
| Associated GPIs | 21100028002025 21100028002030 |
| GCN Sequence Number | 059162 |
| GCN Sequence Number Description | oxaliplatin VIAL 50 MG/10ML INTRAVEN |
| HIC3 | V1A |
| HIC3 Description | ANTINEOPLASTIC - ALKYLATING AGENTS |
| GCN | 24699 |
| HICL Sequence Number | 016687 |
| HICL Sequence Number Description | OXALIPLATIN |
| Brand/Generic | Generic |
| Proprietary Name | oxaliplatin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | oxaliplatin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION, CONCENTRATE |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/mL |
| Substance Name | OXALIPLATIN |
| Labeler Name | Accord Healthcare Inc. |
| Pharmaceutical Class | Platinum-based Drug [EPC], Platinum-containing Compounds [EXT] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207474 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 16729-0332-05 (16729033205)
| NDC Package Code | 16729-332-05 |
|---|---|
| Billing NDC | 16729033205 |
| Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (16729-332-05) / 20 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2018-05-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |